Advances in Peritoneal Dialysis

  Previous Article | Back to Volume | Next Article
  Abstract | References | Citation | Download | Preview | Statistics
Sample volume 1
Title Prothrombin Fragment 1 2 (F1 2) in Effluent Is a Useful Marker for Peritoneal Permeability in Peritoneal Dialysis Patients Using Neutral Dialysate
Author Tsutomu Sakurada, Shigeki Kojim, Daisuke Oishi, Kenichiro Koitabashi, Masahito Miyamoto, Sayuri Shirai, Yugo Shibagaki, Takashi Yasuda, Takeo Sato, Kenjiro Kimura
Abstract
To clarify the influence of neutral dialysate (ND) on peritoneum, we examined changes in peritoneal permeability and in various markers of the coagulation and fibrinolytic system in effluent and the correlations between peritoneal permeability and those markers in peritoneal dialysis (PD) patients using ND. We evaluated 14 patients (8 men, 6 women; mean age: 58.6 ± 12.0 years) who started PD using ND. The peritoneal equilibration test (PET) was performed to assess dialysate-to-plasma ratio for creatinine (D/P Cr) as peritoneal permeability. Coagulation markers [thrombin–antithrombin complex, fibrin monomer (FM), prothrombin fragment 1 2 (F1 2)] and fibrinolytic markers (fibrin degradation products, D-dimer) in effluent were 
also measured. At 2 years, FM in effluent was significantly lower (p = 0.006). The other markers and the D/P Cr did not change significantly. At the initiation of PD and at 2 years, D/P Cr was significantly correlated with F1 2 (r = 0.70 and 0.76 respectively, p < 0.01). Furthermore, multiple regression analysis showed that only F1 2 was correlated with D/P Cr at 2 years (r = 0.79, p = 0.004). These results suggest that ND has little influence on coagulation and fibrinolytic markers in effluent. In addition, F1 2 is a useful marker for peritoneal permeability in PD patients using ND.
Citation
References
1 Kawanishi H, Kawaguchi Y, Fukui H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, 
controlled, multicenter study. Am J Kidney Dis 
2004;44:729–37.
2 Kawaguchi Y, Kawanishi H, Mujais S, Topley N, 
Oreopoulos DG. Encapsulating peritoneal sclerosis: 
definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal 
Dialysis. Perit Dial Int 2000;20(suppl 4):S43–55.
3 Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, 
Krediet RT. Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 1997;51:888–93.
4 Yamagata K, Tomida C, Koyama A. Intraperitoneal 
hyaluronan production in stable continuous ambulatory peritoneal dialysis patients. Perit Dial Int 
1999;19:131–7.
5 Hirahara I, Inoue M, Okuda K, Ando Y, Muto S, Kusano E. The potential of matrix metalloproteinase-2 as 
a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis—a multicentre study 
in Japan. Nephrol Dial Transplant 2007;22:560–7.
6 De Vriese AS, Tilton RG, Stephan CC, Lameire NH. 
Vascular endothelial growth factor is essential for 
hyperglycemia-induced structural and functional alterations of peritoneal membrane. J Am Soc Nephrol 
2001;12:1734–41.
7 Fujimori A, Naito H, Miyazaki T, et al. Elevation of 
interleukin 6 in the dialysate reflects peritoneal stimuli and deterioration of peritoneal function. Nephron 
1996;74:471–2.
8 Homma S, Masunaga Y, Kurosu M, Inoue M, Sakurai 
T, Asano Y. Changes in peritoneal coagulation and 
fibrinolysis after discontinuation of chronic peritoneal 
dialysis. Perit Dial Int 2002;22:178–83.
9 Twardowski ZJ, Nolph KD, Khanna R, et al. Peritoneal equilibration test. Perit Dial Bull 1987;7:138–47.
10 Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: the effects 
of peritoneal dialysis and peritonitis. Nephrol Dial 
Transplant 1996;11:498–506.
11 Williams JD, Craig KJ, Topley N, et al. on behalf 
of the Peritoneal Biopsy Study Group. Morphologic 
changes in the peritoneal membrane of patients with 
renal disease. J Am Soc Nephrol 2002;13:470–9.
12 Krediet RT, Zweers MM, van der Wal AC, Struijk 
DG. Neoangiogenesis in the peritoneal membrane. 
Perit Dial Int 2000;20(suppl 2):S19–25.
13 Sitter T, Spannagl M, Schiffl H, Held E, van Hinsbergh VW, Kooistra T. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis 
of CAPD patients: the role of mesothelial cells. 
Nephrol Dial Transplant 1995;10:677–83.
14 Whitaker D, Papadimitriou JM, Walters M. The 
mesothelium: its fibrinolytic properties. J Pathol 
1982;136:291–9.
15 Preloznik Zupan I, Sabovic M, Salobir B, Buturovic 
Ponikvar J. Characterization of the pro-thrombotic 
state in CAPD patients. Ren Fail 2008;30:597–602.
16 Goedde M, Sitter T, Schiffl H, Bechtel U, Schramm 
W, Spannagl M. Coagulation and fibrinolysis-related 
antigens in plasma and dialysate of CAPD patients. 
Perit Dial Int 1997;17:162–6.
Keywords Peritoneal permeability, prothrombin fragment 1 2, F1 2
Download Full PDF Download
  Previous Article | Back to Volume | Next Article
Share
Search in articles
Statistics
Journal Published articles
APD 49
Journal Hits
APD 164446
Journal Downloads
APD 165
Total users online -